On cash pay, a telehealth program adds its fee to a brand GLP-1 price it does not lower: $839 a year on WeightWatchers' Med+ 12-month plan, $1,678 at LifeMD and $2,388 at Calibrate, on top of $4,188 for 12 months of the Wegovy pen at NovoCare's $349, per first-party pages read October 15, 2026.
None of these fees include the medication. Brand prices are manufacturer self-pay offers that can change, and some intro prices end December 31, 2026.
On cash pay, the brand drug price comes from the manufacturer: NovoCare for Wegovy, LillyDirect for Zepbound and Foundayo. A telehealth program supplies the prescriber and follow-up and bills a separate monthly fee. This piece prices that layer over 12 months.
How much does a telehealth program add to Wegovy or Zepbound?
Between nothing and about $2,400 a year. Every program that prints a fee bills medication separately: WeightWatchers says "Cost of GLP-1 medications not included," Calibrate says "prescription medications are not included in the membership cost," and LifeMD says its price "does not include the monthly program & provider fee of $149."
Manufacturer self-pay prices:
- Wegovy pen (NovoCare): $349 a month for 0.25 mg to 2.4 mg; $399 for Wegovy HD 7.2 mg. New patients pay $199 for each of two fills of 0.25 mg and 0.5 mg through December 31, 2026.
- Wegovy pill (NovoCare): $149 for 1.5 mg, $199 for 4 mg, $299 for 9 mg and 25 mg.
- Zepbound vial or KwikPen (LillyDirect): $299 for 2.5 mg, $399 for 5 mg, $449 for 7.5–15 mg if each refill comes within 45 days; otherwise $499 at 7.5 mg and $699 at 10–15 mg.
- Foundayo (LillyDirect): $149 for 0.8 mg; $149 (2.5 mg) and $199 (5.5 mg) reduced through December 31, 2026; $299 for 9 mg and, with 45-day refills, 14.5 and 17.2 mg (regular $349). Source: archived LillyDirect page dated September 25, 2026; lilly.com blocked direct reads on October 15.
Program fee vs. going direct: the 12-month table
| Program | What the fee is (exact quote) | Medication included? | Brand drug cost source | 12-month program fee (USD) | 12-month total with Wegovy pen (USD) | Read / status |
|---|---|---|---|---|---|---|
| Direct, no program | NovoCare: "$349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg" | Drug only; you bring a prescription | NovoCare Pharmacy | $0 (plus your prescriber's visit cost) | $4,188 | Oct 15, 2026 / verified |
| Sequence (WeightWatchers Med+) | "$25 for your first month ... membership continues for $74/mo (12-month plan) or $84/mo (6-month plan)"; "Cost of GLP-1 medications not included." | No | NovoCare / LillyDirect, or insurance | $839 (12-month plan) | $5,027 | Oct 15, 2026 / verified |
| Calibrate | "$199/month" with "Initial 3-month commitment required"; "Lab tests and prescription medications are not included" | No | Not stated for cash pay | $2,388 | $6,576 | Oct 15, 2026 / verified |
| LifeMD | "monthly program & provider fee of $149 (first month discounted to $39 today)" | No | Prints "Wegovy Pen Starting At Just $199" | $1,678 | $5,866 | Oct 15, 2026 / verified |
| Ro | $39 first month, $74–149/month membership; Wegovy pill or Foundayo "starting at $149" for new patients | No | Manufacturer pricing | $853–$1,678 (if reported fees hold) | $5,041–$5,866 | Reported; page returned 403 on Oct 15, 2026 |
| Noom Med | Brand medications "starting at $39 plus any out-of-pocket cost for the medication itself" | No | Insurance or self-pay | Not computable: no ongoing monthly fee printed | Not computable | Oct 15, 2026 / brand fee unpriced |
| Alloy | "$99 monthly fee" (printed on its compounded pages) | No (compounded drug priced separately) | No brand path priced | Not computed for brand | Not computed | Oct 15, 2026 / compounded only |
| Form Health | No price printed | Not stated | Not stated | Not printed | Not printed | Oct 15, 2026 / unpriced |
| Hims & Hers | Not re-read on October 15, 2026 | — | — | — | — | Unreachable (403) |
Math: Sequence $25 + 11 × $74 = $839. Calibrate 12 × $199 = $2,388. LifeMD $39 + 11 × $149 = $1,678. Ro's range is $39 + 11 × $74 = $853 to $39 + 11 × $149 = $1,678; Ro's page was not re-read, so treat it as reported. See also our pricing transparency review.
Do you need a telehealth program to buy from LillyDirect or NovoCare?
No, but you need a prescriber. LillyDirect says "Zepbound requires a valid prescription from a licensed healthcare provider" and asks your doctor to send it to LillyDirect Pharmacy, which routes it to a dispensing pharmacy such as Amazon Pharmacy or Walmart Pharmacy. NovoCare's Wegovy page says "Wegovy is a prescription medication," links to resources "to find a doctor you can meet virtually," and offers NovoCare Pharmacy delivery.
LillyDirect's page (September 30, 2026 snapshot) lists independent virtual-care options whose rates "do not include medication costs": Counsel Health at $29 a visit or $25 a month on annual pricing; Sesame at $99 a month or $59 a month annual; Weight Watchers at $149 a month or $74 a month annual. Lilly adds that it "does not endorse or recommend these health care providers."
What does the program fee actually buy?
Mostly the clinical relationship: intake, a prescriber, dose changes, refills and, in some programs, coaching or a dietitian. Calibrate's fee excludes labs. WeightWatchers' fee covers non-GLP-1 medications filled through Carepoint, but not GLP-1s. No program we read lowers the manufacturer's price. LifeMD's "$199" Wegovy pen price matches NovoCare's intro offer.
Check who prescribes and how dose changes work with our provider evaluation checklist. Individual reviews: Sequence, Calibrate, LifeMD.
Worked examples: 12 months with real arithmetic
1. Wegovy pen, already on a maintenance dose. $349 × 12 = $4,188 direct. Add Sequence's 12-month plan: $4,188 + $839 = $5,027, which is 20% more. Add LifeMD: $4,188 + $1,678 = $5,866 (40% more). Add Calibrate: $4,188 + $2,388 = $6,576 (57% more).
2. Wegovy pen, new patient. With both intro fills by December 31, 2026: 2 × $199 + 10 × $349 = $398 + $3,490 = $3,888 direct, or $4,727 with Sequence ($3,888 + $839).
3. Zepbound, standard step-up. Assumption: one month at 2.5 mg, two at 5 mg, then nine at 7.5 mg or higher, refilled within 45 days each time. $299 + 2 × $399 + 9 × $449 = $299 + $798 + $4,041 = $5,138 direct. With LifeMD: $5,138 + $1,678 = $6,816. Miss the 45-day window at 10 mg and that month costs $699, not $449. These totals cover 12 fills; LillyDirect counts a month as 28 days, so a full calendar year takes a 13th fill ($449 more at these doses). Dose detail is on our Zepbound page.
4. Wegovy pill. Assumption: one month each at 1.5 mg, 4 mg and 9 mg, then nine months at 25 mg. $149 + $199 + $299 + 9 × $299 = $647 + $2,691 = $3,338 direct. With Calibrate: $3,338 + $2,388 = $5,726, so the program adds 72%. Your prescriber sets the schedule; see our Wegovy page.
What this means for you
- If you have a prescriber, going direct is the lowest-cost brand route in this comparison.
- If you have no prescriber, the lowest listed rate on LillyDirect's page works out to $300 a year (12 × $25), versus $839 for WeightWatchers' 12-month plan.
- A program can earn its fee if you want dose-change, side-effect and nutrition support. Weigh that against the 20–72% it adds above.
- Watch the terms. Calibrate requires a 3-month commitment; WeightWatchers plans auto-renew "at the same monthly rate."
- Brand prices are offers. The Wegovy $199 intro and Foundayo's reduced prices end December 31, 2026.
How do compounded programs compare?
Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. The price gap is large. NexLife lists $115 a month for tirzepatide and $95 for semaglutide on 12-month plans ($1,380 and $1,140 a year), with the same price at every dose and no membership. It is not the lowest: Mondae prints $126 and $87 for one month, below NexLife’s month-to-month prices, and Eden Health prints $99 a month for semaglutide with no membership. Our compounded vs. brand guide covers the trade-offs.
Frequently asked questions
Is a telehealth membership for Wegovy or Zepbound worth it?
It depends on whether you already have a prescriber. If you do, buying direct from NovoCare or LillyDirect avoids a fee of $839 to $2,388 a year in our table. If you don't, a program supplies the prescriber and follow-up. Price that service against cheaper prescriber options listed on LillyDirect's page.
Does any telehealth program include the brand drug in its fee?
None that we read on October 15, 2026. WeightWatchers, Calibrate, LifeMD and Noom Med all say medication is billed separately. You pay the manufacturer's self-pay price, such as $349 a month for the Wegovy pen, or your insurance copay, plus the program fee.
Can I buy Zepbound from LillyDirect without a telehealth company?
Yes, if you have a valid prescription from a licensed provider. LillyDirect asks your doctor to send it to LillyDirect Pharmacy, which routes it to a dispensing pharmacy. If you need a prescriber, LillyDirect lists independent virtual-care options but says it does not endorse them.
What does a year of Wegovy cost through WeightWatchers?
On the 12-month Med+ plan, the membership is $25 for the first month and $74 a month after, or $839 for the year. Add 12 months of the Wegovy pen at NovoCare's $349, which is $4,188, and the total is $5,027. New patients can lower the drug cost with the two $199 intro fills.
Are compounded GLP-1 programs the same as brand programs?
No. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same as Zepbound or Wegovy. They usually cost less: NexLife lists $115 and $95 a month on 12-month plans, and Mondae prints lower month-to-month prices, as does Eden Health for semaglutide. Compare the product, not only the price.
Sources
- Wegovy savings and self-pay, NovoCare (Novo Nordisk), read October 15, 2026.
- Zepbound on LillyDirect, Eli Lilly and Company (archived snapshot September 30, 2026), read October 15, 2026.
- LillyDirect: find telehealth care, Eli Lilly and Company (archived snapshot September 30, 2026), read October 15, 2026.
- Foundayo on LillyDirect, Eli Lilly and Company (archived snapshot September 25, 2026), read October 15, 2026.
- Weight loss medication (Med+), WeightWatchers, read October 15, 2026.
- Pricing, Calibrate, read October 15, 2026.
- Weight management, LifeMD, read October 15, 2026.
- Weight loss pricing, Ro, returned 403 on October 15, 2026 (figures reported).
- Noom Med, Noom, read October 15, 2026.
- Compounded semaglutide, Alloy, read October 15, 2026.
- Tirzepatide plans, NexLife, read October 15, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss, U.S. FDA (current as of October 1, 2026), read October 15, 2026.